<DOC>
	<DOCNO>NCT01385995</DOCNO>
	<brief_summary>The investigator perform randomize , cross-over control clinical trial compare 8 week Continuous Positive Airway Pressure ( CPAP ) 8 week sham-CPAP patient moderate severe Sleep Disordered Breathing ( SDB ) impair glucose tolerance . A rigorous assessment metabolic response SDB treatment group great clinical significance sample high risk develop diabetes . The paradigm shift CPAP mode prevention affect clinical practice field primary care sleep medicine .</brief_summary>
	<brief_title>Effects Treatment Sleep Apnea Metabolic Syndrome</brief_title>
	<detailed_description>There control study address whether treatment sleep apnea improves glucose tolerance . This randomized , double-blind cross-over study subject sleep apnea ( apnea hypopnea index &gt; 15 ) impair glucose tolerance . Subjects randomized 8 week Continuous Positive Airway Pressure ( CPAP ) sham-CPAP , follow alternate therapy one month wash-out . After treatment , subject undergo 2-hour oral glucose tolerance testing , polysomnography , actigraphy , measurement index glucose control . The investigator intend analyze change glucose metabolism insulin sensitivity patient sleep apnea CPAP intervention .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>moderate severe Sleep Disordered Breathing ( SDB ) define Apnea Hypopnea Index ( AHI ) &gt; 15 evidence Impaired Glucose Tolerance ( IGT ) define mean 2hour Oral Glucose Tolerance Test ( OGTT ) glucose &gt; 140 mg/dl calculate two 2hour OGTTs perform within 3 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>